Management
We are a tightly knit team driven by our companies Vision – To improve the Quality of Life for couples with infertility problems around the world.
John Lempert
Chief Executive Officer
Our CEO John Lempert is leading the organisation in development and go-to-market, including investor relations and strategic partnerships.
John studied Law at Lund University and is a Certified Dental Technician from Gothenburgs Odontological Faculty, and has extensive experience from corporate governance and business development in the medical device sector for more than 35 years.
Kushagr Punyani
Chief Scientific Officer
Our CSO Kush Punyani is leading the team developing and designing Spermosens’ revolutionary male fertility diagnostic device.
Kush has an MPhil in Engineering from Lund University/NanoLund where he worked on development of microfluidic devices for diagnostic applications. His undergraduate work in India with Prof Sudha Srivastava laid the foundation of Spermosens’ core technology.
Project & Office
Chemutai Beatrice
Project & Office Coordinator
Chemutai holds a Master of Science in International Development & Management from Lund University, and a Bachelor of Arts degree in Sociology & Social Work from CUEA.
Chemutai has several years experience from working with Project Management and as Project Assistant in an international environment. Over the past 4 years, Beatrice has been actively involved in planning and executing innovative project management solutions for companies in both nonprofit and for-profit sectors in Sweden, South Africa and Kenya.
Human Resources
Pernilla Agardh
Human Resources Consultant
Pernilla Agardh, owner and founder of Agardh Consulting AB, has a Bachelor of Economics from the School of Economics and Management, Lund University, and studies in Psychology at Lund University. She has 20 years experience from working in the pharmaceutical industry.
Pernilla is a Certified recruiter at DNV GL and has a long experience from working with HR, recruitment and search to different levels and industries.
Finance
Christian Svensson
CFO
Christian Svensson has more than 25 years of experience within finance in both multi-national as well as SME companies. Since 2008 working as independent consultant supporting smaller companies listed on NASDAQ Stockholm as CFO.
Development Partners
Zimmer & Peacock
Z&P is a valued partner in Spermosens Development Team on the development of a disposable chip for the rapid assessment of male fertility based on Spermosens’ IP around the direct measurement of spermatozoa within the semen, and prediction of the fusion capacity to the oocyte (egg cell).
Z&P has deep knowledge in, and experience from, the development of electrochemical biosensors, and these capabilities are being leveraged by Spermosens to deliver a product to the market, in an investment efficient manner, leveraging capital insertion with ROI.
Spermosens understanding of the fertility market, and the patent pending platform technology will supply the answer to solving problems within the IVF market. Spermosens male-fertility diagnostic products are expected to lead to fewer cycles performed to fertilisation and conception.
…we are thrilled to be selected as a trusted development partner with Spermosens and delighted to be guided by Spermosens mission . We are impressed by Spermosens break-through technology and their go-to-market strategy.
– Z&P CEO Mr. Even Zimmer
IP Development Partners
HØIBERG
Stefan has a broad interdisciplinary background from his undergraduate studies at the nanoengineering program, and subsequent PhD studies in Physics at Lund University, Sweden. Throughout his PhD he focused on the application of nano and microstructures for the analysis of particles, for the investigation of biological samples. In addition Stefan has an extensive knowledge about miniaturization of diagnostic devices for lab-on-chip applications.
The profound technical background has been a perfect match for Spermosens, and has been an instrumental component when Stefan and his colleagues at the renowned patent law firm HØIBERG, have developed a viable IP strategy on behalf of Spermosens. The Spermosens and HØIBERG teams work closely together to maintain and develop the patent portfolio of Spermosens.
Peter Holm is a European Patent Attorney, Partner and Country Manager for Sweden at the patent law firm HØIBERG. Together with Stefan Holm Nygaard, Peter is acting as Spermosens’ strategic IP advisor. Peter has a PhDin Biochemistry and Biophysics from Karolinska Institutet, Sweden and has been working as a patent attorney at HØIBERG since 2006, assisting startup companies and individual researchers within the lifescience field, with the development of their IP strategy.
Case responsible attorney for the Spermosens patent portfolio.
